Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m
Asahi Kasei has signed a definitive agreement to acquire all issued shares of German-based Aicuris Anti-infective Cures for approximately €780m…
All articles by Salong Debbarma
Salong Debbarma
-
-
Quotient and Ipsen extend partnership for ultra-rare disease therapy
Quotient Sciences has extended its commercial partnership with Ipsen, focusing on the production of Sohonos (Palovarotene) for fibrodysplasia ossificans progressiva…
-
IQVIA to acquire Charles River drug discovery assets
IQVIA Holdings has signed an agreement to acquire selected discovery service assets from Charles River Laboratories, aiming to expand its…
-
Novo Nordisk and Vivtex collaborate for oral medicines development
Novo Nordisk and Vivtex have entered a partnership focused on developing next-generation oral biologic therapies to treat obesity, diabetes and…
-
Slate Medicines raises $130m in funds to progress anti-PACAP treatments
Slate Medicines has secured a $130m Series A financing round aimed at advancing anti-pituitary adenylate cyclase-activating polypeptide (PACAP) migraine therapies.…
-
NorthX Biologics and Demeetra collaborate on GMP manufacturing and CLD
NorthX Biologics and Demeetra have entered a strategic partnership focused on integrated cell line development (CLD) and good manufacturing practice…
-
FDA accepts Beren Therapeutics’ NDA for Niemann-Pick disease
Beren Therapeutics has received the US Food and Drug Administration (FDA) acceptance to review its New Drug Application (NDA) for…
-
AbbVie announces $380m investment in North Chicago API facilities
AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing facilities at its current…
-
AstraZeneca’s Calquence plus venetoclax gains approval in US to treat CLL
AstraZeneca has secured approval in the US for Calquence (acalabrutinib) plus venetoclax as the first all-oral, fixed-duration regimen to treat…
-
Roche receives FDA acceptance for giredestrant combo NDA
Roche has obtained acceptance from the US Food and Drug Administration (FDA) for its new drug application (NDA) submitted for…